Journey through the spectacular landscape of melanocortin 1 receptor
Pigment Cell & Melanoma Research · 2024
DOI: 10.1111/pcmr.13180 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pigment Cell & Melanoma Research, 2024. Verfasst von P R Upadhyay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Receptor, Melanocortin, Type 1, Melanocytes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIEHS NIH HHS, NIEHS p30 ES006096, BLRD VA.
Abstract (Originalsprache)
The physiological role of α‐melanocyte stimulating hormone in regulating integumental pigmentation of many vertebrate species has been recognized since the 1960's. However, its physiological significance for human pigmentation remained enigmatic until the 1990's. α‐Melanocyte stimulating hormone and related melanocortins are synthesized locally in the skin, primarily by keratinocytes, in addition to the pituitary gland, and therefore act as paracrine factors for melanocytes. Human melanocytes express the melanocortin 1 receptor, which recognizes α‐melanocyte stimulating hormone and the related adrenocorticotropic hormone as agonists. This review summarizes the current knowledge of the pleotropic effects of the activated melanocortin 1 receptor that maintain human melanocyte homeostasis by regulating melanogenesis and the response to environmental stressors, mainly solar radiation. Certain allelic variants of the melanocortin 1 receptor gene are associated with specific pigmentary phenotypes in various human populations. Variants associated with red hair phenotype compromise the function of the encoded receptor. Activation of the human melanocortin 1 receptor regulates eumelanin synthesis and enhances DNA damage response of melanocytes to solar radiation and oxidative stressors. We describe how synthetic selective melanocortin 1 receptor agonists can be efficacious as sunless tanning agents, for treatment of vitiligo and photosensitivity disorders, and for prevention of skin cancer, including melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Förderung
- NIEHS NIH HHS
- NIEHS p30 ES006096
- BLRD VA
- University of Cincinnati Cancer Center
- U.S. Department of Veterans Affairs
- Melanoma Know More
Zitieren
APA
Upadhyay, P. R., Swope, V. B., Starner, R. J., Koikov, L., & Abdel-Malek, Z. A. (2024). Journey through the spectacular landscape of melanocortin 1 receptor. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13180
Vancouver
Upadhyay PR, Swope VB, Starner RJ, Koikov L, Abdel-Malek ZA. Journey through the spectacular landscape of melanocortin 1 receptor. Pigment Cell & Melanoma Research. 2024. doi:10.1111/pcmr.13180
BibTeX
@article{Upadhyay2024,
author = {Upadhyay, P R and Swope, V B and Starner, R J and Koikov, L and Abdel-Malek, Z A},
title = {Journey through the spectacular landscape of melanocortin 1 receptor},
journal = {Pigment Cell & Melanoma Research},
year = {2024},
doi = {10.1111/pcmr.13180}
}
EUVIMED